Form D · Biotechnology
Sorrento Therapeutics, Inc.
San Diego, CA · CIK 0001466679
Offering snapshot reported Jun 19, 2009 · SEC filing
- Reported sold
- $2.3M Offering amount: $2.3M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 10, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 19, 2009 | Initial | $2,300,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-132103
Source: Form D, filed Jun 19, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Henry Ji | Director, Executive |
| Antonius Schuh | Director, Executive |
| Steve Zaniboni | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10054 Mesa Ridge Court, Suite 122
San Diego, CA, 92121
San Diego, CA, 92121